Otolin-1 and otoconin-90 as serum biomarkers for benign paroxysmal positional vertigo: a narrative review
Author:
Open Access
- 15 September 2026
- journal article
- Published by The Korean Balance Society in Research in Vestibular Science
- Vol. 25 (3) , 83-90
Abstract
Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, arising from degeneration and displacement of otoconia from the utricular macula into the semicircular canals. Although diagnosis relies on clinical history and provocative positional maneuvers, it may be challenging when positional nystagmus is subtle or absent or when positional testing cannot be adequately performed. Otolin-1 and otoconin-90 (OC90), the two principal structural proteins of the otoconial matrix, can cross the blood-labyrinth barrier and can be detected and quantified in peripheral serum, making them candidate biomarkers of otoconial degeneration. This narrative review summarizes current evidence for otolin-1 and OC90 as diagnostic and prognostic biomarkers in BPPV. Across multiple case-control studies and one meta-analysis, serum otolin-1 has been consistently elevated in patients with BPPV compared with healthy controls, and may also be associated with disease severity and recurrence. In contrast, findings for OC90 have been inconsistent, with studies reporting increased, decreased, or unchanged levels in BPPV relative to controls. Despite these promising findings, substantial heterogeneity in laboratory methods, potential biological confounders, inconsistent timing of blood sampling, and the lack of comparisons with other vestibular disorders currently limit their clinical applicability. Standardized assays and well-designed prospective studies incorporating serial measurements and appropriate disease-control groups are needed to determine whether these proteins can serve as reliable and specific biomarkers for BPPV.Keywords
This publication has 29 references indexed in Scilit:
- Serum Estradiol Correlates With Benign Paroxysmal Positional Vertigo in Postmenopausal WomenEndocrine Practice, 2022
- Serum otolin-1 as a biomarker for benign paroxysmal positional vertigo: a case-control studyThe Journal of Laryngology & Otology, 2021
- Inner Ear Proteins as Potential BiomarkersOtology & Neurotology, 2020
- A Relationship Between Blood Levels of Otolin-1 and Vitamin DOtology & Neurotology, 2018
- Age-Related Increase in Blood Levels of Otolin-1 in HumansOtology & Neurotology, 2017
- Preliminary Report on the Investigation of the Association Between BPPV and Osteoporosis Using BiomarkersOtology & Neurotology, 2015
- Mechanisms of otoconia and otolith developmentDevelopmental Dynamics, 2014
- Benign Paroxysmal Positional VertigoNew England Journal of Medicine, 2014
- Otoconin-90 deletion leads to imbalance but normal hearing: A comparison with other otoconia mutantsNeuroscience, 2008
- Gene targeting reveals the role of Oc90 as the essential organizer of the otoconial organic matrixDevelopmental Biology, 2007